StemMedical raising up to EUR 18m Series B for stem cell therapy platform
StemMedical, a Danish developer of a stem cell therapy platform for aesthetic and reconstructive surgery, is in the process of raising a Series B of EUR 15m–EUR 18m, CEO Klaus Langhoff-Roos said. The company already has half of the capital committed, and aims to close the...
Continue Reading